Literature DB >> 1390218

Rare occurrence of P53 gene mutations in multiple myeloma.

C Preudhomme1, T Facon, M Zandecki, M Vanrumbeke, J L Laï, E Nataf, M H Loucheux-Lefebvre, J P Kerckaert, P Fenaux.   

Abstract

We looked for mutations of exons 5-8 of the P53 gene in bone marrow cell from 37 cases of multiple myeloma, using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis and DNA sequencing. 25 patients also had cytogenetic analysis. A point mutation, leading to an amino acid change in the P53 protein was found in only one case, involving exon 5. These findings suggest that P53 mutations are very rare in multiple myeloma, and that this disease may be categorized among the few neoplasms where P53 abnormalities have very limited role, if any.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1390218     DOI: 10.1111/j.1365-2141.1992.tb08253.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  p53 gene mutations in multiple myeloma.

Authors:  R G Owen; S A Davis; J Randerson; A C Rawstron; F Davies; J A Child; A S Jack; G J Morgan
Journal:  Mol Pathol       Date:  1997-02

Review 2.  Multiple myeloma: increasing evidence for a multistep transformation process.

Authors:  M Hallek; P L Bergsagel; K C Anderson
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

3.  p53 mutations in multiple myeloma.

Authors:  S Paydaś; B Sahin; E Seyrek; S Zorludemir
Journal:  Mol Pathol       Date:  1997-12

Review 4.  Genetic events in the pathogenesis of multiple myeloma.

Authors:  W J Chng; O Glebov; P L Bergsagel; W M Kuehl
Journal:  Best Pract Res Clin Haematol       Date:  2007-12       Impact factor: 3.020

5.  Immunohistochemical analysis of cyclin D1 and p53 in multiple myeloma: relationship to proliferative activity and prognostic significance.

Authors:  O Markovic; D Marisavljevic; V Cemerikic; N Suvajdzic; N Milic; M Colovic
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

6.  Understanding the multiple biological aspects leading to myeloma.

Authors:  Eileen M Boyle; Faith E Davies; Xavier Leleu; Gareth J Morgan
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

7.  Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature.

Authors:  Marta Lionetti; Marzia Barbieri; Martina Manzoni; Sonia Fabris; Cecilia Bandini; Katia Todoerti; Filomena Nozza; Davide Rossi; Pellegrino Musto; Luca Baldini; Antonino Neri
Journal:  Oncotarget       Date:  2016-04-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.